Trial Profile
A Multi-center, Double-blind, Parallel-arm Study to Investigate Pharmacodynamics and Pharmacokinetics of OPC-41061 in Patients With Hepatic Edema
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 20 May 2016
Price :
$35
*
At a glance
- Drugs Tolvaptan (Primary)
- Indications Liver disorders
- Focus Adverse reactions; Pharmacodynamics; Pharmacokinetics
- Sponsors Otsuka Pharmaceutical
- 19 Apr 2014 New trial record